Author:
Hoori Ammar,Al-Kindi Sadeer,Hu Tao,Song Yingnan,Wu Hao,Lee Juhwan,Tashtish Nour,Fu Pingfu,Gilkeson Robert,Rajagopalan Sanjay,Wilson David L.
Abstract
AbstractWhole-heart coronary calcium Agatston score is a well-established predictor of major adverse cardiovascular events (MACE), but it does not account for individual calcification features related to the pathophysiology of the disease (e.g., multiple-vessel disease, spread of the disease along the vessel, stable calcifications, numbers of lesions, and density). We used novel, hand-crafted calcification features (calcium-omics); Cox time-to-event modeling; elastic net; and up and down synthetic sampling methods for imbalanced data, to assess MACE risk. We used 2457 CT calcium score (CTCS) images enriched for MACE events from our large no-cost CLARIFY program (ClinicalTrials.gov Identifier: NCT04075162). Among calcium-omics features, numbers of calcifications, LAD mass, and diffusivity (a measure of spatial distribution) were especially important determinants of increased risk, with dense calcification (> 1000HU, stable calcifications) associated with reduced risk Our calcium-omics model with (training/testing, 80/20) gave C-index (80.5%/71.6%) and 2-year AUC (82.4%/74.8%). Although the C-index is notoriously impervious to model improvements, calcium-omics compared favorably to Agatston and gave a significant difference (P < 0.001). The calcium-omics model identified 73.5% of MACE cases in the high-risk group, a 13.2% improvement as compared to Agatston, suggesting that calcium-omics could be used to better identity candidates for intensive follow-up and therapies. The categorical net-reclassification index was NRI = 0.153. Our findings from this exploratory study suggest the utility of calcium-omics in improved risk prediction. These promising results will pave the way for more extensive, multi-institutional studies of calcium-omics.
Funder
National Heart, Lung, and Blood Institute
National Institute on Minority Health and Health Disparities
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Beswick, A. D., Brindle, P., Fahey, T. & Ebrahim, S. A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement) (Royal College of General Practitioners, 2008).
2. Orringer, C. E. et al. The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction. J. Clin. Lipidol. 15, 33–60 (2021).
3. Golub, I. S. et al. Major global coronary artery calcium guidelines. JACC Cardiovasc. Imaging 16, 98–117 (2023).
4. Osawa, K., Nakanishi, R. & Budoff, M. Coronary artery calcification. Glob. Heart 11, 287–293 (2016).
5. Song, Y. et al. Improved bias and reproducibility of coronary artery calcification features using deconvolution. J. Med. Imaging https://doi.org/10.1117/1.JMI.10.1.014002 (2023).